← The Wire
GILDNasdaq
GILEAD SCIENCES, INC.
Biological Products, (No Diagnostic Substances) · DE · CIK 882095
Gilead Sciences discovers, develops, and delivers innovative medicines to prevent and treat life-threatening diseases like HIV, viral hepatitis, COVID-19, and cancer
🔥 High media attention
$155.93B
Market cap
$126.33
Last close
-1.2%
1D
+1.2%
5D
6.9M
Volume
Price · last 39 sessions-4.8%
May 4L $121.48 · H $136.30Jun 29
172
Total filings
May 20, 2026
Last filing
12/31
Fiscal year end
8-KMaterial Agreement · New Debt / ObligationMay 20, 20268-KResults of OperationsMay 7, 20268-KShareholder VoteMay 4, 20268-KReg FD Disclosure · Company UpdateApr 28, 20268-KMaterial Agreement · Reg FD DisclosureFeb 23, 20268-KResults of OperationsFeb 10, 20268-KExecutive ChangeNov 19, 20258-KResults of OperationsOct 30, 20258-KReg FD DisclosureOct 6, 20258-KExecutive ChangeAug 14, 20258-KResults of OperationsAug 7, 20258-KBylaw AmendmentAug 4, 20258-KShareholder VoteMay 8, 20258-KResults of OperationsApr 24, 20258-KExecutive ChangeMar 12, 20258-KResults of OperationsFeb 11, 20258-KMaterial Agreement · New Debt / ObligationNov 20, 20248-KResults of OperationsNov 6, 20248-KResults of OperationsAug 8, 20248-KExecutive ChangeJul 17, 20248-KBylaw Amendment · Shareholder VoteMay 9, 20248-KResults of OperationsApr 25, 20248-KReg FD Disclosure · Company UpdateMar 22, 20248-KExecutive ChangeMar 14, 20248-KMaterial Agreement · Company UpdateFeb 12, 20248-KResults of OperationsFeb 6, 20248-KExecutive ChangeFeb 2, 20248-KResults of OperationsNov 7, 20238-KMaterial Agreement · New Debt / ObligationSep 14, 20238-KReg FD DisclosureAug 16, 20238-KResults of OperationsAug 3, 20238-KExecutive Change · Shareholder VoteMay 5, 20238-KResults of OperationsApr 27, 20238-KBylaw AmendmentFeb 6, 20238-KResults of OperationsFeb 2, 20238-KResults of OperationsOct 27, 20228-KReg FD DisclosureSep 12, 20228-KResults of OperationsAug 2, 20228-KExecutive ChangeJul 28, 20228-KExecutive ChangeMay 31, 20228-KShareholder VoteMay 5, 20228-KResults of OperationsApr 28, 20228-KReg FD DisclosureMar 7, 20228-KResults of OperationsFeb 1, 20228-KResults of OperationsFeb 1, 20228-KExecutive ChangeJan 6, 20228-KResults of Operations · Company UpdateOct 28, 20218-KResults of OperationsJul 29, 20218-KShareholder VoteMay 14, 20218-KResults of OperationsApr 29, 20218-KResults of OperationsFeb 4, 20218-KResults of OperationsJan 11, 20218-KExecutive ChangeDec 8, 20208-KResults of OperationsOct 28, 20208-KAcquisition / Disposition · Company UpdateOct 23, 20208-KExecutive ChangeOct 22, 20208-KMaterial Agreement · New Debt / ObligationSep 30, 20208-KMaterial AgreementSep 29, 20208-KMaterial Agreement · Company UpdateSep 14, 20208-KResults of OperationsJul 30, 20208-KExecutive ChangeJun 16, 20208-KShareholder VoteMay 8, 20208-KResults of OperationsApr 30, 20208-KMaterial Agreement · Company UpdateMar 2, 20208-KResults of OperationsFeb 4, 20208-KExecutive ChangeJan 31, 20208-KResults of OperationsOct 24, 20198-KExecutive ChangeOct 15, 20198-KCompany UpdateAug 27, 20198-KResults of OperationsJul 30, 20198-KMaterial AgreementJul 18, 20198-KExecutive ChangeJul 17, 20198-KExecutive ChangeJul 17, 20198-KExecutive ChangeMay 29, 20198-KBylaw Amendment · Shareholder VoteMay 9, 20198-KResults of OperationsMay 2, 20198-KExecutive ChangeMay 1, 20198-KExecutive ChangeMar 1, 20198-KResults of OperationsFeb 4, 20198-KExecutive ChangeDec 10, 2018
Insider Activity
In the 90 days to Mar 27, 2026: 4 sold $45.4M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 27, 2026 | O'Day Daniel PatrickChairman & CEO | Sell | 10,000 | $136.82 | $1.4M |
| Mar 16, 2026 | Mercier JohannaChief Comm & Corp Aff Officer | Sell | 3,000 | $144.23 | $433K |
| Mar 16, 2026 | Dickinson Andrew DChief Financial Officer | Sell | 3,000 | $144.23 | $433K |
| Feb 27, 2026 | O'Day Daniel PatrickChairman & CEO | Sell | 6,419 | $145.18 | $932K |
| Feb 27, 2026 | O'Day Daniel PatrickChairman & CEO | Sell | 3,481 | $144.04 | $501K |
| Feb 27, 2026 | O'Day Daniel PatrickChairman & CEO | Sell | 100 | $145.71 | $15K |
| Feb 17, 2026 | Mercier JohannaChief Comm & Corp Aff Officer | Sell | 18,405 | $154.18 | $2.8M |
| Feb 17, 2026 | Mercier JohannaChief Comm & Corp Aff Officer | Sell | 9,395 | $154.91 | $1.5M |
| Feb 17, 2026 | Dickinson Andrew DChief Financial Officer | Sell | 3,000 | $154.43 | $463K |
| Feb 17, 2026 | Mercier JohannaChief Comm & Corp Aff Officer | Sell | 200 | $155.62 | $31K |
| Feb 5, 2026 | O'Day Daniel PatrickChairman & CEO | Sell | 115,640 | $150.00 | $17.3M |
| Jan 28, 2026 | O'Day Daniel PatrickChairman & CEO | Sell | 5,032 | $139.54 | $702K |
| Jan 28, 2026 | O'Day Daniel PatrickChairman & CEO | Sell | 4,968 | $140.24 | $697K |
| Jan 23, 2026 | O'Day Daniel PatrickChairman & CEO | Sell | 115,640 | $135.00 | $15.6M |
| Jan 20, 2026 | Bluestone JeffreyDirector | Sell | 5,000 | $123.50 | $618K |
| Jan 15, 2026 | Dickinson Andrew DChief Financial Officer | Sell | 3,000 | $124.31 | $373K |
| Jan 15, 2026 | Mercier JohannaChief Commercial Officer | Sell | 3,000 | $124.31 | $373K |
| Dec 29, 2025 | O'Day Daniel PatrickChairman & CEO | Sell | 10,000 | $124.83 | $1.2M |
| Dec 15, 2025 | Mercier JohannaChief Commercial Officer | Sell | 3,000 | $122.00 | $366K |
| Dec 15, 2025 | Dickinson Andrew DChief Financial Officer | Sell | 3,000 | $122.00 | $366K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
🔥 High media attentionCoverage (30d): 8 reputable articles · skews ▼ negative.
MarketWatchGilead Sciences Inc. stock underperforms Friday when compared to competitors despite daily gains3d agoMarketWatchGilead Sciences Inc. stock outperforms competitors despite losses on the day11d agoMarketWatchGilead Sciences Inc. stock underperforms Wednesday when compared to competitors12d agoMarketWatchGilead Sciences Inc. stock outperforms competitors on strong trading day13d agoMarketWatchGilead Sciences Inc. stock underperforms Tuesday when compared to competitors20d ago
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance